David J Rog
- Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosisDavid J Rog
Walton Centre for Neurology and Neurosurgery, University of Liverpool, Liverpool, United Kingdom
Neurology 65:812-9. 2005..Central pain in multiple sclerosis (MS) is common and often refractory to treatment...
- Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosisDavid J Rog
Walton Centre for Neurology and Neurosurgery, Liverpool, UK
Clin J Pain 23:473-81. 2007..The Neuropathic Pain Scale (NPS) has received preliminary validation in peripheral neuropathic pain conditions. The aim of this study was to validate its use in MS central pain syndromes...
- Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trialDavid J Rog
Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom
Clin Ther 29:2068-79. 2007..Delta(9)-Tetrahydrocannabinol/cannabidiol (THC/CBD), an endocannabinoid system modulator, has demonstrated efficacy for up to 4 weeks in randomized controlled trials in the treatment of CNP in patients with MS...